-
Verigy Reports Disappointing 3Q Guidance
Wednesday, November 24, 2010 - 9:04amGoldman Sachs has published a research report on Verigy Ltd. (NASDAQ: VRGY) after the company reported disappointed guidance in its 3Q results. In the report, Goldman Sachs writes "We are disappointed that management guided for a loss in 4QCY at the mid-point despite its restructuring actions...
Read More >> -
Verigy (VRGY) Shares Tumble After Disappointing Forecast
Wednesday, February 24, 2010 - 3:53pmShares of Verigy Ltd. (Nasdaq: VRGY) fell nearly 7% a day after the company forecast 2nd quarter results below average analyst expectations. Verigy reported Tuesday after the market close that it expected a loss of between 3 cents and 12 cents per share for the current quarter. Excluding special...
Read More >>
Verigy Ltd.
From Benzinga's Newsdesk
- 8:42 AM Global Hunter Securities Initiates Coverage on Cloud Peak Energy at Neutral, Announces PT of $15
- 08:40 AM Duckwall-Alco May Same-Store Sales Up 1.8% Ex-Fuel
- 08:40 AM UPDATE: Piper Jaffray Lowers Yingli Green Energy's PT
- 08:39 AM Morgan Stanley Will Buy Added 14% of Morgan Stanley Smith Barney
- 8:39 AM Global Hunter Securities Initiates Coverage on Walter Energy at Buy, Announces PT of $79
- 08:36 AM Gaylord Entertainment Company Concludes Strategic Review; Agrees to Sell Gaylord Hotels Brand and Management Company to Marriott
- 08:35 AM G. Willi-Food Reports Q1 2012 Sales up 4.6% From Q1 2011
- 8:35 AM SEC Brings Civil Action Against Advanced Cell
- 08:33 AM ImmunoCellular Therapeutics Says Data on ICT-107 Shows 50% Survival After 4 Years
- 08:32 AM United Financial Bancorp To Acquire New England Bancshares for $91M
- 08:32 AM Duckwall-ALCO Stores Announces Positive May SSS Results +1.8%
- 8:32 AM EU Plans to Publish Guidance on Renewable-Energy Support Programs -Bloomberg
- 08:32 AM Boston Scientific Increases Longevity Projections for Its U.S. Defibrillators
- 08:31 AM NIKE to Divest of Cole Haan and Umbro
- 08:31 AM GE Healthcare Licenses Genomic Biomarker for Lung Cancer from Insight Genetics
Brain Trust
- UPDATE: Pritchard Capital Markets Initiates Buy, $72 PT on SM Energy
- UPDATE: Maxim Group Upgrades Renren to Hold on Price Depreciation
- UPDATE: Sterne Agee Downgrades Finish Line to Neutral on Anemic Core Growth
- Duckwall-Alco May Same-Store Sales Up 1.8% Ex-Fuel
- UPDATE: Piper Jaffray Lowers Yingli Green Energy's PT
- Morgan Stanley Will Buy Added 14% of Morgan Stanley Smith Barney
- Gaylord Entertainment Company Concludes Strategic Review; Agrees to Sell Gaylord Hotels Brand and Management Company to Marriott
- G. Willi-Food Reports Q1 2012 Sales up 4.6% From Q1 2011
- ImmunoCellular Therapeutics Says Data on ICT-107 Shows 50% Survival After 4 Years
- Duckwall-ALCO Stores Announces Positive May SSS Results +1.8%
- Is Facebook Secretly Cloning the iPhone 5?
- David Einhorn's Greenlight Capital Letter to Investors Defends Apple, Doesn't Mention Herbalife
- Was IBM Smart to Ban Siri?
- James Altucher Article Sends Neonode Soaring
- Why Einhorn Is Wrong About Apple
- 5 Small-Cap Short Ideas
- Facebook and Apple Together at Last?
- Stocks to Watch for the All Things Digital Conference: AAPL, ORCL, P, LNKD, ZNGA
- Social Media Chatter on Dell Around Its Earnings Report
- Mako Surgical Recovers After Decline of More Than 40%
